Trial record 1 of 16 for:    "Arrhythmogenic right ventricular dysplasia"
Previous Study | Return to List | Next Study

Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (DVDA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00999947
Recruitment Status : Completed
First Posted : October 22, 2009
Last Update Posted : November 25, 2013
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris

Brief Summary:
The purpose of this trial is to study the genetic and phenotypic aspects of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C), and determine the impact of genetic testing in clinical practice.

Condition or disease
Cardiomyopathy Arrhythmogenic Right Ventricular Dysplasia

  Show Detailed Description

Study Type : Observational
Actual Enrollment : 351 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Genetic Study of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
Study Start Date : September 2006
Actual Primary Completion Date : March 2013
Actual Study Completion Date : March 2013

Primary Outcome Measures :
  1. Determine the genetic origin in patients with ARVD/C whatever the familial context [ Time Frame: at inclusion ]

Biospecimen Retention:   Samples With DNA
blood sample

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   10 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Unrelated patients with ARVD/C. A clinical diagnosis of ARVD/C is made according to the established European Society of Cardiology / International Society and Federation of Cardiology Task Force major and minor criteria (Task Force 1994)

+ All available relatives will be proposed for enrollement in the study


Inclusion Criteria:

  • Patient with DVDA diagnostic confirmed
  • Acceptance even follow-up
  • Informed consent

Exclusion Criteria:

  • Impossible to understand the notice information about study
  • Not affiliated with social protection

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00999947

Pitié-Salpêtrière Hospital
Paris, France, 75013
Sponsors and Collaborators
Assistance Publique - Hôpitaux de Paris
Principal Investigator: Philippe Charron, MD, PhD Pitié-Salpêtrière Hospital

Responsible Party: Assistance Publique - Hôpitaux de Paris Identifier: NCT00999947     History of Changes
Other Study ID Numbers: P051067
First Posted: October 22, 2009    Key Record Dates
Last Update Posted: November 25, 2013
Last Verified: October 2012

Keywords provided by Assistance Publique - Hôpitaux de Paris:
mutation screening
phenotype-genotype analysis
desmosomal genes

Additional relevant MeSH terms:
Arrhythmogenic Right Ventricular Dysplasia
Heart Diseases
Cardiovascular Diseases
Heart Defects, Congenital
Cardiovascular Abnormalities
Congenital Abnormalities